Why it was recalled
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Product description
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1
Lot numbers, UPCs & expiration codes
Lot #: 20250620OXY-1, Expiration date 10/18/2025
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0015-2026
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- Sep 16, 2025
- FDA report date
- Oct 22, 2025
- Quantity
- 853/500 mL bags
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- IntegraDose Compounding Services LLC
Original FDA data
Every field from FDA enforcement report D-0015-2026, exactly as published.
Show all FDA fields
- City
- Minneapolis
- State
- MN
- Status
- Ongoing
- Country
- United States
- Event ID
- 97641
- Address
- 719 Kasota Ave Se
- Code information
- Lot #: 20250620OXY-1, Expiration date 10/18/2025
- Postal code
- 55414-2842
- Report date
- Oct 22, 2025
- Product type
- Drugs
- Recall number
- D-0015-2026
- Classification
- Class I
- Recalling firm
- IntegraDose Compounding Services LLC
- Product quantity
- 853/500 mL bags
- Reason for recall
- Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Sep 16, 2025
- Initial firm notification
- Letter
- Center classification date
- Oct 10, 2025